Illumina, Harvard Pilgrim Health Care Ink Risk-Sharing Deal for Whole-Genome Sequencing

NEW YORK – Illumina and Harvard Pilgrim Health Care announced on Tuesday a risk-sharing agreement that will make whole-genome sequencing (WGS) available to certain Harvard Pilgrim patients beginning Jan. 1, 2021.

Under the terms of the deal, Harvard Pilgrim will cover WGS, through its network of lab providers, for pediatric patients meeting specific criteria.